 new antiretrovir agent clinic first clinic trial zidovudin act fall use agent treatment human immunodefici viru hiv infect recent report hiv resist long-term azt therapi sens urgenc develop addit agent use combin azt infect sever new agent variou stage preclin clinic evalu dideoxycytidin dideoxyinosin dideoxydidehydrothymidin azidouridin foscarnet inhibit viral dna synthesi inhibit revers transcriptas other use agent differ stage infect solubl exampl solubl form receptor hiv cell castanospermin new class compound matur process viral glycoprotein potent toxic analogu latter agent n-butyl-deoxynojirimycin phase